No matter how cynical the overall market is, Hims & Hers Health Inc (HIMS) performance over the last week is recorded 42.12%

On Friday, Hims & Hers Health Inc (NYSE: HIMS) was 2.18% up from the session before settling in for the closing price of $59.18. A 52-week range for HIMS has been $9.22 – $59.55.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

Over the past five-year period, the growth rate of yearbook sales for the company of the Consumer Defensive sector was 60.52%. When this article was written, the company’s average yearly earnings per share was at 592.48%. With a float of $178.10 million, this company’s outstanding shares have now reached $209.44 million.

Considering the fact that the conglomerate employs 1046 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 77.58%, operating margin of 2.84%, and the pretax margin is 4.16%.

Hims & Hers Health Inc (HIMS) Breakdown of a Key Holders of the stock

Also, it is sometimes useful to examine the sentiment of large-scale investors toward Hims & Hers Health Inc stocks. The insider ownership of Hims & Hers Health Inc is 18.79%, while institutional ownership is 74.98%. The most recent insider transaction that took place on Feb 12 ’25, was worth 3,026,624. In this transaction Chief Operating Officer of this company sold 67,687 shares at a rate of $44.71, taking the stock ownership to the 706,872 shares. Before that another transaction happened on Feb 12 ’25, when Company’s Officer proposed sale 67,687 for $46.34, making the entire transaction worth $3,136,616.

Hims & Hers Health Inc (HIMS) Recent Fiscal highlights

Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.22 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 592.48% per share during the next fiscal year.

Hims & Hers Health Inc (NYSE: HIMS) Trading Performance Indicators

You can see what Hims & Hers Health Inc (HIMS) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 1.82. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 10.64. Likewise, its price to free cash flow for the trailing twelve months is 88.30.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.43, a number that is poised to hit 0.11 in the next quarter and is forecasted to reach 0.52 in one year’s time.

Technical Analysis of Hims & Hers Health Inc (HIMS)

Compared to the last year’s volume of 13.69 million, its volume of 22.24 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 93.59%. Additionally, its Average True Range was 3.89.

During the past 100 days, Hims & Hers Health Inc’s (HIMS) raw stochastic average was set at 91.04%, which indicates a significant increase from 87.33% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 98.61% in the past 14 days, which was lower than the 109.33% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $32.59, while its 200-day Moving Average is $22.68. Nevertheless, the first resistance level for the watch stands at $64.00 in the near term. At $67.53, the stock is likely to face the second major resistance level. The third major resistance level sits at $70.22. If the price goes on to break the first support level at $57.78, it is likely to go to the next support level at $55.09. Now, if the price goes above the second support level, the third support stands at $51.57.

Hims & Hers Health Inc (NYSE: HIMS) Key Stats

There are 218,479K outstanding shares of the company, which has a market capitalization of 13.21 billion. As of now, sales total 872,000 K while income totals -23,550 K. Its latest quarter income was 401,560 K while its last quarter net income were 75,590 K.